ORIGINAL ARTICLE
OPEN ACCESS ‑ PEER‑REVIEWED
|
Clinical Significance of HSCARG for Atherosclerotic Coronary Heart Disease and Reduced ROS-Oxidative Stress in in Vivo and in Vitro Models via p47phox by NF-κB ActivityDOI: 10.21470/1678-9741-2021-0183 Publish in: August 3 2025 How to cite this articleZhou X, Zhou S, Li Y, Qian Z, Zeng C, Li Y. Clinical Significance of HSCARG for Atherosclerotic Coronary Heart Disease and Reduced ROS-Oxidative Stress in in Vivo and in Vitro Models via p47phox by NF-κB Activity. Braz J Cardiovasc Surg. 2022;37(5):727-736 |